Elekta's Leksell Gamma Knife Icon precision radiosurgery system CE marked

France's University Hospital La Timone first to install Leksell Gamma Knife Icon, Elekta's latest generation cranial radiosurgery system

Elekta has CE marked its Leksell Gamma Knife® Icon™ precision radiosurgery system, making this latest generation Leksell Gamma Knife platform available in the European market. With stereotactic imaging, online Adaptive DoseControl™, ultra-precise dose delivery and the availability of frameless treatments, Icon is capable of treating virtually any target in the brain, regardless of type, location or volume. The company also announced that University Hospital La Timone (Marseilles, France) had installed the first Icon and will use the system to treat the first patients in July.

"Leksell Gamma Knife Icon is a new concept for performing precision radiosurgery for all types of cranial cases with unlimited clinical and workflow flexibility," says Tomas Puusepp, President and CEO of Elekta. "Clinicians can choose either frame-based or frameless methods to immobilize the patient's head, as well as the option to perform the treatment in a single session or in multiple sessions. Icon is also based on the only technology available that can perform ultra-precise Microradiosurgery™ for the cases where this is required."

Puusepp adds that the system's online Adaptive DoseControl™ and high-definition motion management features ensure the most precise treatments possible, whether frame-based or frameless, as well as an efficient workflow thanks to the complete system and workflow integration.

Professor Jean Régis, MD, a neurosurgeon and program director for University Hospital La Timone's Gamma Knife program, says that Icon presents physicians with two significant opportunities related to the ability to use frameless immobilization.

"The first will be to enlarge the scope of indications by permitting hypofractionation [multiple treatment sessions] to be performed more readily, and also treatment of lesions in additional anatomical sites. This is by virtue of the capability to perform frameless treatments with much better technical control," he says. "The second opportunity is the ability to evaluate shifts in the patient's position and to adapt the dose proactively to account for these movements. This in particular, will push frameless, hypofractionated radiosurgery to a level that doesn't exist today."

University Hospital La Timone physicians are long-time users of the predecessor of Icon, Leksell Gamma Knife® Perfexion™, having been the world's first hospital to treat patients with the system in 2006. In 2010, the hospital used its Perfexion to deliver radiosurgery to the center's 10,000th patient. University Hospital La Timone's Gamma Knifeprogram is 23-years-old and has employed four different versions of Leksell Gamma Knife.

Source:

Elekta

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Elekta. (2023, September 12). Elekta's Leksell Gamma Knife Icon precision radiosurgery system CE marked. News-Medical. Retrieved on December 22, 2024 from https://www.news-medical.net/news/20150610/Elektas-Leksell-Gamma-Knife-Icon-precision-radiosurgery-system-CE-marked.aspx.

  • MLA

    Elekta. "Elekta's Leksell Gamma Knife Icon precision radiosurgery system CE marked". News-Medical. 22 December 2024. <https://www.news-medical.net/news/20150610/Elektas-Leksell-Gamma-Knife-Icon-precision-radiosurgery-system-CE-marked.aspx>.

  • Chicago

    Elekta. "Elekta's Leksell Gamma Knife Icon precision radiosurgery system CE marked". News-Medical. https://www.news-medical.net/news/20150610/Elektas-Leksell-Gamma-Knife-Icon-precision-radiosurgery-system-CE-marked.aspx. (accessed December 22, 2024).

  • Harvard

    Elekta. 2023. Elekta's Leksell Gamma Knife Icon precision radiosurgery system CE marked. News-Medical, viewed 22 December 2024, https://www.news-medical.net/news/20150610/Elektas-Leksell-Gamma-Knife-Icon-precision-radiosurgery-system-CE-marked.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries